The most extensively used tool in atherosclerosis is the CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 system to target genes such as PCSK9, ANGPTL3, apoB, and LDLR. This evidence concerns the gene PCSK9 and atherosclerosis.